Americas Ventilators Market
Based on type, the Americas ventilators market is bifurcated as clinical ventilators and home ventilators. The clinical ventilator segment held the larger market share in 2022 however, home ventilator is anticipated to register the higher CAGR during the forecast period. In the clinical setting, a mechanical ventilator is used to perform ventilation functions on patients with serious respiratory illnesses. It is useful in clinical settings to treat sicknesses and diseases causing respiratory failure, such as pneumonia, chronic obstructive pulmonary disease (COPD), COVID-19, and lung cancer. The ventilator allows gas exchange to be maintained while other treatments are provided to the patient to improve the clinical condition. Ventilation is measured as minute ventilation in the clinical setting and calculated as respiratory rate times the tidal volume. In a mechanically ventilated patient, the CO2 content of the blood can be modified by adjusting the tidal volume or the respiratory rate. The decision to initiate mechanical ventilation should be based on clinical judgment that considers the entire clinical situation.
Clinical Indication Insights
Based on clinical indication, the Americas ventilators market, by clinical indication, is segmented into medical, trauma, neurological, surgical, and others. The medical segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.
Patient Insights
Based on patients, the Americas ventilators market is divided into adult, pediatric, and neonatal. The adult segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.
Mobility Insights
The Americas ventilators market, by mobility, is bifurcated into intensive care ventilators and portable/ transportable ventilators. The intensive care ventilators segment held the larger share of the market in 2022 however, portable/ transportable ventilators is anticipated to register the higher CAGR of the market during the forecast period.
Mode Insights
Based on mode, the Americas ventilators market, is segmented into combined mode ventilation, volume mode ventilation, pressure mode ventilation, neurally adjusted ventilatory assists, inverse ration ventilation, prone ventilation, high frequency oscillatory ventilation, high-frequency percussive ventilation, and others. The combined mode ventilation segment held the largest ventilators market share in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
Interface Insights
The Americas ventilators market, by interface, is bifurcated into invasive and non invasive. The invasive segment held the larger share of the market in 2022 however, non invasive segment is anticipated to register the higher CAGR in the market during the forecast period.
End User Insights
Based on end user, the Americas Ventilators market, is segmented into hospital and clinics, homecare, ambulatory care centers, emergency medical services, and Others. The hospital and clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
The hospitals and clinics segment are expected to hold a major share of the Americas ventilators market owing to the availability of various types of medical ventilators and the growing adoption rate of these devices in hospital settings. The increasing prevalence of respiratory diseases and COVID-19 is also anticipated to propel the ventilators market growth for the segments in the coming years.
Rising healthcare expenditure, lucrative reimbursement policies, and increasing emphasis on better patient outcomes contribute to the Americas ventilators market growth of the hospital and clinics segment. The hospital and clinic segment were influenced by privatization in the US. Many retail clinics fall under private hospitals’ network, which increasingly demand high-quality ventilators. An influx of private players in various countries’ hospitals and the healthcare industry has changed the face of clinics. These clinics have diversified their service offerings and are focused on offering critical care and emergency services, leading to a gradual rise in demand for ventilators from these settings.
Rapidly Increasing Geriatric Population
The rise in life expectancy drives the geriatric population growth. Most people expect to live into their sixties and beyond. According to the 2020 Census, the geriatric population reached 55.8 million (16.8%) of the population of the US in 2020. The population of people aged 65 and above is predicted to increase between 2012 and 2050. About 1 in 6 people in the country were aged 65 and above in 2020. Additionally, as per the data published by the Fraser Institute, the share of the country’s population aged 65 or older increased from 14% in 2010 to 19% in 2022 and is expected to reach 22.5% by 2030.
In Brazil, the aging population is increasing rapidly. According to the data from Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and above (i.e., 13% of the country’s population). By 2030, the population of this age group is expected to reach ~50 million (i.e., 24% of the total population). As per the Brazil Statistical Institute, people aged 65 and above are expected to hold a 36% share of the total population of Brazil by 2050.
Older people are more prone to severe diseases caused by respiratory infections than younger people due to age-related issues, such as frailty, which increases the number of hospitalizations and deaths. The rise in the elderly population has led to an increase in geriatric ailments, leading to a greater requirement for intensive care, which includes mechanical ventilation. According to the CDC database 2020, the number of COPD patients and deaths is much greater among older age groups, contributing to 86% of COPD deaths among these age groups.
Elderly patients are progressively opting for an intensive care unit (ICU) treatment using mechanical ventilation (MV). Noninvasive ventilation (NIV) is a better alternative to be used for elderly patients admitted to hospitals for the treatment of respiratory diseases. According to one of the studies published in Medicina Intensiva, the journal of the Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias, patients aged more than 75 years exhibit significantly greater in-ICU mechanical ventilation requirements.
Aging is the main factor that contributes to the increase in chronic-degenerative disease cases. In a few cases, it leads to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population bolsters the demand for ventilatory support, which is driving the ventilators market growth in Americas.
Americas Ventilators Market: Competitive Landscape and Key Developments
Medtronic Plc, Koninklijke Philips NV, Hamilton Medical AG, Dragerwerk AG & Co KGaA , Vyaire Medical Inc , Getinge AB, ResMed Inc, ICU Medical Inc, Nihon Kohden Corp, and Shenzhen Mindray Bio-Medical Electronics Co Ltd among others are among the key companies operating in the Americas ventilators market. Leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.
- In July 2023, Getinge received clearance from the US FDA for Servo-air Lite, a wall gas-independent non invasive mechanical ventilator. Servo-air Lite is the company’s turbine-driven ventilator for non invasive ventilation. Like all Servo ventilators, it offers ICU-quality ventilation but is more geared towards spontaneously breathing patients needing extra breathing support.
- In January 2023, Getinge launched its new Servo-c mechanical ventilator targeting selected markets, offering lung-protective therapeutic tools to treat pediatric and adult patients. Based on decades of knowledge and with all the essential functionalities needed, Servo-c is intended to make health care accessible and affordable for more hospitals worldwide.
- In July 2022, Nihon Kohden received US FDA 510(k) clearance for its NKV-330 Ventilator System. The NKV-330 is a non invasive ventilator that provides respiratory support to adult and pediatric patients. This system offers invasive and non invasive ventilation and high-flow oxygen therapy. In addition, it provides continuous monitoring of CO2 when using cap-ONE NIV mask. The cap-ONE mask is an NIV interface that allows quality CO2 monitoring directly from the ventilator. The NKV-330 ventilator system is distributed in the US by Nihon Kohden America, Inc.
